{"id":"W1994686939","doi":"10.1186/1744-8603-10-3","title":"“To patent or not to patent? the case of Novartis’ cancer drug Glivec in India”","year":2014,"lang":"en","type":"article","venue":"Globalization and Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Global Health Research; Public Health Ontario; University of Toronto","funders":"","keywords":"Supreme court; Medicine; Patentability; Lawsuit; Appeal; Bosutinib; Law; Generic drug; Political science; Intellectual property; Imatinib; Nilotinib; Drug; Myeloid leukemia; Patent law; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006777938,0.00008584071,0.000252084,0.0001250427,0.00007730917,0.00003097324,0.00009106543,0.00003200048,0.0001604728],"category_scores_gemma":[0.00004612879,0.00007295333,0.00002327241,0.0002948653,0.00001934851,0.0000476944,0.0000551425,0.00005556076,0.00006588477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000136316,"about_ca_system_score_gemma":0.00005159251,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0107679,"about_ca_topic_score_gemma":0.004720935,"domain_scores_codex":[0.9989871,0.00002635091,0.0005114005,0.0002166939,0.00001678449,0.0002416915],"domain_scores_gemma":[0.9994274,0.000023306,0.0001687173,0.000145949,0.000021163,0.000213413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","study_design_scores_codex":[0.0001157552,0.0001270672,0.1472335,0.0001993625,0.00002250482,0.000007680911,0.00500215,0.001448397,0.000003084677,0.797856,0.0129522,0.03503225],"study_design_scores_gemma":[0.002026606,0.000229576,0.6926386,0.00008629544,0.0000062412,0.00002803924,0.0003160195,0.03240639,0.00006618613,0.009444752,0.2623292,0.0004221978],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9537661,0.0004782161,0.001731048,0.04006881,0.000365272,0.0006254357,0.0005253428,0.00001360325,0.002426173],"genre_scores_gemma":[0.9588999,0.0008681605,0.00009158834,0.03995866,0.00005697014,0.00002243276,0.000006215245,0.000008171248,0.00008792513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7884113,"threshold_uncertainty_score":0.9958195,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.157543710964708,"score_gpt":0.3671035804438023,"score_spread":0.2095598694790942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}